1. Ngm Biopharmaceuticals, Inc. (27 from 73 patents)

2. Purdue Research Foundation (1 from 2,660 patents)

3. Amgen Inc. (1 from 1,974 patents)

1. 11564972 - Methods of using compositions comprising variants of FGF19 polypeptides for treating primary biliary cirrhosis in a subject

2. 11370841 - Methods of treating fibroblast growth factor 19-mediated cancers and tumors

3. 11241481 - Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases

4. 11103554 - Methods of using compositions comprising variants of FGF19 polypeptides for reducing bile acid synthesis in a subject having cirrhosis

5. 11065302 - Compositions comprising fusion variants of FGF19 polypeptides

6. 11066454 - Compositions comprising variants and fusions of FGF19 polypeptides

7. 10758590 - Methods of using compositions comprising variants and fusions of FGF 19 polypeptides for treating diabetes

8. 10744185 - Methods of using variants of FGF19 polypeptides for the treatment of pruritus

9. 10597751 - Ligand assisted chromatography for metal ion separation

10. 10456449 - Methods and uses for modulating bile acid homeostasis and treatment of bile acid disorders and diseases

11. 10413590 - Methods of using compositions comprising variants of FGF19 polypeptides for reducing body mass in a subject

12. 10398758 - Compositions comprising variants of FGF19 polypeptides and uses thereof for the treatment of hyperglycemic conditions

13. 10369199 - Methods of using variants of FGF19 polypeptides for the treatment of cancer

14. 9974833 - Methods of using compositions comprising variants and fusions of FGF19 polypeptides for modulating bile acid homeostasis in a subject having pregnancy intrahepatic cholestasis

15. 9963494 - Methods of using compositions comprising variants and fusions of FGF19 polypeptides for reducing glucose levels in a subject